Quent Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.8K	Buy	369 +45	+14%	+$2.62K	﹤0.01%	982
2025 Q4	$19.3K	Sell	324 -202	-38%	-$11K	﹤0.01%	1001
2025 Q3	$28.5K	Buy	+526	New	+$30.1K	﹤0.01%	759
2025 Q2	–	Sell	-189	Closed	-$13.4K	–	400
2025 Q1	$13.4K	Buy	189 +33	+21%	+$2.22K	﹤0.01%	856
2024 Q4	$10.3K	Sell	156 -100	-39%	-$6.7K	﹤0.01%	931
2024 Q3	$18K	Sell	256 -135	-35%	-$11.3K	﹤0.01%	905
2024 Q2	$32.2K	Buy	391 +145	+59%	+$12.1K	﹤0.01%	743
2024 Q1	$21.5K	Sell	246 -112	-31%	-$10K	﹤0.01%	863
2023 Q4	$34.5K	Buy	358 +23	+7%	+$2.04K	﹤0.01%	706
2023 Q3	$29.6K	Sell	335 -1,223	-78%	-$109K	﹤0.01%	707
2023 Q2	$135K	Buy	1,558 +23	+1%	+$2.16K	0.02%	358
2023 Q1	$147K	Buy	1,535 +1,374	+853%	+$142K	0.03%	337
2022 Q4	$16.7K	Hold	161	–	–	﹤0.01%	804
2022 Q3	$14K	Buy	161 +12	+8%	+$1.07K	﹤0.01%	799
2022 Q2	$12K	Hold	149	–	–	﹤0.01%	793
2022 Q1	$11K	Buy	149 +30	+25%	+$2.51K	﹤0.01%	887
2021 Q4	$11K	Buy	+119	New	+$9.82K	﹤0.01%	803